-+ 0.00%
-+ 0.00%
-+ 0.00%

Intelligent Bio Solutions starts multi-site study supporting FDA 510(k) filing for codeine fingerprint drug test

PUBT·06/02/2026 12:33:39
Listen to the news
Intelligent Bio Solutions starts multi-site study supporting FDA 510(k) filing for codeine fingerprint drug test
  • Intelligent Bio Solutions launched a multi-site method comparison study to support an FDA 510(k) filing for its fingerprint sweat drug test for codeine.
  • Results have not been presented yet; enrollment and data collection are expected to finish by end-July 2026, then included in the submission.
  • The study aims to show the system delivers reliable results in workplace settings when used by typical screening staff without specialized lab training.
  • Findings will be checked against lab-based confirmation testing, strengthening the clinical evidence package alongside a separate cut-off study that began in January 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020830PRIMZONEFULLFEED9728820) on June 02, 2026, and is solely responsible for the information contained therein.